Mutant Alpha-1-Antitrypsin Compositions and Use Thereof

Eli Chaim Lewis (Inventor), LIOR Yotam (Inventor)

Research output: Patent


The present invention provides mutant alpha 1-antitrypsin proteins, pharmaceutical compositions comprising the same, and methods of use thereof in treatment of subjects with an inflammatory disease or disorder.
Original languageEnglish GB
Patent numberUS20200140524A1
StatePublished - 7 May 2020


Dive into the research topics of 'Mutant Alpha-1-Antitrypsin Compositions and Use Thereof'. Together they form a unique fingerprint.

Cite this